EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Visual Function Assessment in Geographic Atrophy: A Review

Ye Li, Lauren N Ayton iD, Adrian T Fung

Clinical & Experimental Ophthalmology · 2026-03 · 54 (2) · 260-274

DOI: 10.1111/ceo.70037 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical & Experimental Ophthalmology, online erschienen am 12.12.2025. Verfasst von Ye Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Royal Brisbane and Women's Hospital, Brisbane, Australia. Hauptthemen laut MEDLINE: Geographic Atrophy, Visual Acuity. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Geographic atrophy (GA) causes significant vision impairment and reduction in vision‐related quality of life. Fundus autofluorescence (FAF) is the gold standard of structural assessment of GA but is a surrogate marker for vision loss, which can be assessed by tests of visual function and functional vision. Best corrected visual acuity (BCVA), the most commonly used visual function test in ophthalmology, is a poor metric for assessing GA progression. This is because GA usually only affects the fovea in its late stage, grows slowly, and spared areas of retina may not ‘fit’ larger reading chart letters, confounding measurements. For this reason, tests of visual function have been developed, including low luminance visual acuity (LLVA), reading speed, contrast sensitivity, microperimetry, flicker perimetry, and dark adaptation. Functional vision measures are approximated through patient‐reported outcomes using various questionnaires. This review explores the strength of association between FAF and tests of visual function in patients with GA. A range of targeted, prespecified endpoints of visual function testing should be included in future clinical trials for treatments of GA, focusing on GA lesion phenotypes that are known to progress rapidly in order to maximise the likelihood of identifying positive results. This is critical in jurisdictions where proof of functional benefit is required for regulatory approval of treatments for GA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Geographic AtrophyVisual AcuityHumansFluorescein AngiographyContrast SensitivityVisual FieldsVisual Field TestsVision TestsQuality of LifeDark AdaptationTomography, Optical Coherence

Stichwörter der Autor:innen

functional visiongeographic atrophyvision function

Autor:innen und Institutionen

  • Department of Ophthalmology, Royal Brisbane and Women's Hospital, Brisbane, Australia.
  • Department of Optometry and Vision Sciences, University of Melbourne, Melbourne, Australia.
  • Department of Surgery (Ophthalmology), University of Melbourne, Melbourne, Australia.
  • Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Australia.
  • Save Sight Institute, Specialty of Clinical Ophthalmology and Eye Health, The University of Sydney, Sydney, Australia.
  • Department of Ophthalmology, Westmead Hospital, Sydney, Australia.

ORCID-Profile: Lauren N Ayton

Zitieren

APA

Li, Y., Ayton, L. N., & Fung, A. T. (2026). Visual Function Assessment in Geographic Atrophy: A Review. Clinical & Experimental Ophthalmology, 54(2), 260-274. https://doi.org/10.1111/ceo.70037

Vancouver

Li Y, Ayton LN, Fung AT. Visual Function Assessment in Geographic Atrophy: A Review. Clinical & Experimental Ophthalmology. 2026;54(2):260-274. doi:10.1111/ceo.70037

BibTeX
@article{Li2026,
  author = {Li, Ye and Ayton, Lauren N and Fung, Adrian T},
  title = {Visual Function Assessment in Geographic Atrophy: A Review},
  journal = {Clinical & Experimental Ophthalmology},
  year = {2026},
  volume = {54},
  number = {2},
  pages = {260--274},
  doi = {10.1111/ceo.70037}
}
Kostenlos starten →